|
CH575014A5
(enExample)
|
1973-05-25 |
1976-04-30 |
Alusuisse |
|
|
JPS5328498Y2
(enExample)
|
1973-08-17 |
1978-07-18 |
|
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
BR9204244A
(pt)
|
1992-10-26 |
1994-05-03 |
Cofap |
Ferro fundido cinzento
|
|
AU689090B2
(en)
|
1992-12-01 |
1998-03-26 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with L-selectin
|
|
US5876950A
(en)
|
1995-01-26 |
1999-03-02 |
Bristol-Myers Squibb Company |
Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
|
|
FR2729855A1
(fr)
|
1995-01-26 |
1996-08-02 |
Oreal |
Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
|
|
JP3946256B2
(ja)
|
1995-09-11 |
2007-07-18 |
協和醗酵工業株式会社 |
ヒトインターロイキン５受容体α鎖に対する抗体
|
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
|
CN1241944A
(zh)
|
1996-12-05 |
2000-01-19 |
乔治敦大学 |
具有抗病毒活性的鼠尾草种类的提取物
|
|
JPH11101542A
(ja)
|
1997-09-29 |
1999-04-13 |
Sanyo Electric Co Ltd |
冷蔵庫
|
|
KR100479790B1
(ko)
|
1998-04-30 |
2005-03-30 |
타녹스 인코퍼레이티드 |
G - c s f 수용체의 항진 항체 및 이를 스크리닝하는 방법
|
|
FR2780062B1
(fr)
|
1998-06-17 |
2000-07-28 |
Rhone Poulenc Rorer Sa |
Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
|
|
AU759689B2
(en)
|
1998-06-24 |
2003-04-17 |
Chugai Seiyaku Kabushiki Kaisha |
Novel hemopoietin receptor proteins
|
|
CA2342967A1
(en)
|
1998-12-08 |
2000-06-15 |
Biovation Limited |
Modifying protein immunogenicity
|
|
AU4952400A
(en)
|
1999-06-02 |
2000-12-28 |
Chugai Research Institute For Molecular Medicine, Inc. |
Novel hemopoietin receptor protein nr10
|
|
DE60025241T2
(de)
|
1999-09-27 |
2007-01-11 |
Chugai Seiyaku K.K. |
HäMOPOIETINREZEPTOR-PROTEIN, NR12
|
|
CN1326880A
(zh)
|
2000-06-06 |
2001-12-19 |
周伟中 |
双层站台火车站
|
|
US20030096339A1
(en)
|
2000-06-26 |
2003-05-22 |
Sprecher Cindy A. |
Cytokine receptor zcytor17
|
|
DK1325115T3
(en)
|
2000-06-26 |
2016-11-21 |
Zymogenetics Inc |
CYTOKINRECEPTOR ZCYTOR17
|
|
WO2002077230A1
(fr)
|
2001-03-26 |
2002-10-03 |
Chugai Seiyaku Kabushiki Kaisha |
Variants d'epissage nr10
|
|
EP1754719A3
(en)
|
2001-04-05 |
2007-05-16 |
Immuno-Biological Laboratories Co., Ltd. |
Anti-osteopontin antibody and use thereof
|
|
US7064186B2
(en)
|
2002-01-18 |
2006-06-20 |
Zymogenetics, Inc. |
Cytokine zcytor17 ligand
|
|
ES2382800T3
(es)
|
2002-01-18 |
2012-06-13 |
Zymogenetics, Inc. |
Multímeros Zcytor17 receptores de citocinas
|
|
WO2003072740A2
(en)
|
2002-02-25 |
2003-09-04 |
Genentech, Inc. |
Novel type-1 cytokine receptor glm-r
|
|
US7579000B2
(en)
|
2002-05-01 |
2009-08-25 |
Bayer Schering Pharma Ag |
Tissue factor targeted antibodies as anticoagulants
|
|
MXPA04010851A
(es)
|
2002-05-01 |
2005-02-14 |
Schering Ag |
Proteinas de fusion de trombomodulina dirigidas al factor tisular novedoso como anticoagulantes.
|
|
TW200407335A
(en)
|
2002-07-22 |
2004-05-16 |
Chugai Pharmaceutical Co Ltd |
Non-neutralizing antibody to inhibit the inactivation of activated protein C
|
|
KR100499989B1
(ko)
|
2002-12-27 |
2005-07-07 |
네오바이오다임 주식회사 |
아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 아사이알로 α1-산 당단백질에 대한 단일클론 항체, 이 항체를 포함하는 면역크로마토그래피 스트립 및 이 스트립를 이용한 아사이알로 α1-산 당단백질 측정방법
|
|
US20040223970A1
(en)
|
2003-02-28 |
2004-11-11 |
Daniel Afar |
Antibodies against SLC15A2 and uses thereof
|
|
ES2527414T3
(es)
|
2003-03-04 |
2015-01-23 |
Alexion Pharmaceuticals, Inc. |
Método para el tratamiento de una enfermedad autoinmune mediante la inducción de la presentación de antígeno mediante células presentadoras de antígeno que inducen tolerancia
|
|
AU2004223836A1
(en)
|
2003-03-24 |
2004-10-07 |
Zymogenetics, Inc. |
Anti-IL-20 antibodies and binding partners and methods of using in inflammation
|
|
AU2005213965B2
(en)
|
2004-02-12 |
2009-11-19 |
Lexicon Pharmaceuticals, Inc. |
Gene disruptions, compositions and methods relating thereto
|
|
JP2008504289A
(ja)
|
2004-06-25 |
2008-02-14 |
メディミューン，インコーポレーテッド |
部位特異的突然変異誘発による哺乳動物細胞における組換え抗体の産生の増加
|
|
KR100624013B1
(ko)
|
2004-06-25 |
2006-09-19 |
주식회사 녹십자홀딩스 |
동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
|
|
EP1671642A1
(en)
|
2004-12-15 |
2006-06-21 |
Universite D'angers |
Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof.
|
|
US8993319B2
(en)
|
2004-12-28 |
2015-03-31 |
Innate Pharma S.A. |
Monoclonal antibodies against NKG2A
|
|
ES2579758T3
(es)
|
2005-01-28 |
2016-08-16 |
Zymogenetics, Inc. |
Preparaciones homogéneas de IL-31
|
|
JP2008530132A
(ja)
|
2005-02-14 |
2008-08-07 |
ザイモジェネティクス， インコーポレイテッド |
Ｉｌ−３１ｒａアンタゴニストを用いて皮膚障害を治療する方法
|
|
EP1856539B1
(en)
|
2005-02-14 |
2015-10-21 |
ZymoGenetics, Inc. |
Methods of predicting therapeutic response in atopic dermatitis to il-31 antagonists
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
|
WO2006122079A1
(en)
*
|
2005-05-06 |
2006-11-16 |
Zymogenetics, Inc. |
Il-31 monoclonal antibodies and methods of use
|
|
JP2009526756A
(ja)
|
2006-01-10 |
2009-07-23 |
ザイモジェネティクス， インコーポレイテッド |
Ｉｌ−３１ｒａアンタゴニストおよびｏｓｍｒｂアンタゴニストを用いて神経組織における疼痛および炎症を治療する方法
|
|
EP2463305B1
(en)
|
2006-01-12 |
2016-05-11 |
Alexion Pharmaceuticals, Inc. |
Antibodies to OX-2/CD200 and uses thereof
|
|
NO347079B1
(no)
|
2006-03-23 |
2023-05-08 |
Bioarctic Neuroscience Ab |
Forbedrede protofibrilselektive antistoffer og anvendelse derav
|
|
ES2429407T3
(es)
|
2006-06-08 |
2013-11-14 |
Chugai Seiyaku Kabushiki Kaisha |
Agente preventivo o remedio para enfermedades inflamatorias
|
|
ES2415655T3
(es)
|
2006-06-15 |
2013-07-26 |
The Board Of Trustees Of The University Of Arkansas |
Anticuerpos monoclonales que reconocen selectivamente Metanfetamina y compuestos similares a Metanfetamina
|
|
EP2594586B1
(en)
|
2006-09-01 |
2014-08-27 |
ZymoGenetics, Inc. |
IL-31 monoclonal antibodies and methods of use
|
|
CN101600456A
(zh)
*
|
2006-12-11 |
2009-12-09 |
惠氏公司 |
治疗il-13相关疾病和监测il-13相关疾病治疗的方法和组合物
|
|
JP2010512402A
(ja)
|
2006-12-11 |
2010-04-22 |
ワイス エルエルシー |
Ｉｌ−１３関連障害を治療するための方法および組成物ならびにその治療をモニター観察するための方法
|
|
ATE494306T1
(de)
|
2007-02-14 |
2011-01-15 |
Vaccinex Inc |
Humanisierte anti-cd100-antikörper
|
|
RS58098B1
(sr)
|
2007-02-23 |
2019-02-28 |
Merck Sharp & Dohme |
Anti-il-23p19 antitela proizvedena genetičkim inženjerstvom
|
|
WO2008114733A1
(ja)
|
2007-03-16 |
2008-09-25 |
Kyowa Hakko Kirin Co., Ltd. |
抗Claudin-4抗体
|
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
|
CN101687038A
(zh)
|
2007-07-10 |
2010-03-31 |
霍夫曼-拉罗奇有限公司 |
新型制剂
|
|
AU2008304756B8
(en)
|
2007-09-26 |
2015-02-12 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-IL-6 receptor antibody
|
|
ES2687808T3
(es)
|
2007-09-26 |
2018-10-29 |
Chugai Seiyaku Kabushiki Kaisha |
Región constante de anticuerpo modificado
|
|
MX369784B
(es)
*
|
2007-09-26 |
2019-11-21 |
Chugai Pharmaceutical Co Ltd |
Metodo de modificacion del punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
|
|
US8431127B2
(en)
|
2007-12-05 |
2013-04-30 |
Chugai Seiyaku Kabushiki Kaisha |
Method for treating pruritus comprising administering an NR10 antagonist
|
|
KR20160074019A
(ko)
|
2007-12-05 |
2016-06-27 |
추가이 세이야쿠 가부시키가이샤 |
항ｎｒ１０ 항체 및 그의 이용
|
|
JP5744522B2
(ja)
|
2007-12-07 |
2015-07-08 |
ザイモジェネティクス， インコーポレイテッド |
Ｉｌ−３１に特異的なヒト化抗体分子
|
|
KR20160062207A
(ko)
*
|
2008-12-05 |
2016-06-01 |
추가이 세이야쿠 가부시키가이샤 |
항ｎｒ１０ 항체 및 그의 이용
|
|
JP2010210772A
(ja)
*
|
2009-03-13 |
2010-09-24 |
Dainippon Screen Mfg Co Ltd |
液晶表示装置の製造方法
|
|
EP2475376B1
(en)
|
2009-06-17 |
2016-03-30 |
BioMarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
WO2013012022A1
(ja)
|
2011-07-19 |
2013-01-24 |
中外製薬株式会社 |
アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
MX363193B
(es)
|
2012-09-07 |
2019-03-14 |
Regeneron Pharma |
Metodos para tratar la dermatitis atopica mediante la administracion de un antagonista de il-4r.
|
|
US9198898B2
(en)
*
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
JP5650871B1
(ja)
|
2013-06-28 |
2015-01-07 |
中外製薬株式会社 |
そう痒を伴う疾患に罹患した患者のｉｌ−３１アンタゴニストによる治療に対する応答を予測する方法
|
|
TWI738648B
(zh)
|
2015-04-14 |
2021-09-11 |
日商中外製藥股份有限公司 |
含有ｉｌ－３１拮抗劑作為有效成分之異位性皮膚炎的預防用及／或治療用醫藥組合物
|
|
GB201703063D0
(en)
|
2017-02-24 |
2017-04-12 |
Arecor Ltd |
Stabilized antibody protein solutions
|
|
WO2018156367A1
(en)
|
2017-02-24 |
2018-08-30 |
Kindred Biosciences, Inc. |
Anti-il31 antibodies for veterinary use
|
|
KR20200014738A
(ko)
|
2017-04-11 |
2020-02-11 |
키닉사 파마슈티컬스, 리미티드 |
안정한 항-osmr 항체 제형
|
|
WO2019225568A1
(ja)
|
2018-05-21 |
2019-11-28 |
中外製薬株式会社 |
ガラス容器に封入された凍結乾燥製剤
|
|
JP6845973B1
(ja)
|
2019-11-20 |
2021-03-24 |
中外製薬株式会社 |
抗体含有製剤
|
|
EP4209227A4
(en)
|
2020-09-01 |
2024-05-29 |
Chugai Seiyaku Kabushiki Kaisha |
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF PRURITUS IN DIALYSIS CONTAINING AN IL-31 ANTAGONIST AS ACTIVE INGREDIENT
|